CN110809468A - 诱导软骨发生的方法 - Google Patents
诱导软骨发生的方法 Download PDFInfo
- Publication number
- CN110809468A CN110809468A CN201880042328.6A CN201880042328A CN110809468A CN 110809468 A CN110809468 A CN 110809468A CN 201880042328 A CN201880042328 A CN 201880042328A CN 110809468 A CN110809468 A CN 110809468A
- Authority
- CN
- China
- Prior art keywords
- compound
- administration
- administered
- pharmaceutically acceptable
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/452—Lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762489397P | 2017-04-24 | 2017-04-24 | |
US62/489,397 | 2017-04-24 | ||
PCT/US2018/028939 WO2018200411A1 (en) | 2017-04-24 | 2018-04-23 | Methods for inducing chondrogenesis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110809468A true CN110809468A (zh) | 2020-02-18 |
Family
ID=63919101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880042328.6A Pending CN110809468A (zh) | 2017-04-24 | 2018-04-23 | 诱导软骨发生的方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210361600A1 (ru) |
EP (1) | EP3615021A4 (ru) |
JP (2) | JP2020517597A (ru) |
KR (1) | KR20190137904A (ru) |
CN (1) | CN110809468A (ru) |
AU (1) | AU2018257769A1 (ru) |
CA (1) | CA3060518A1 (ru) |
MA (1) | MA48479A (ru) |
RU (1) | RU2019136884A (ru) |
WO (1) | WO2018200411A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220257572A1 (en) * | 2019-02-13 | 2022-08-18 | Yale University | Methods of treating epilepsy |
FI129515B (en) | 2020-11-06 | 2022-03-31 | Salarusta Oy | FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012129562A2 (en) * | 2011-03-24 | 2012-09-27 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
CN105228626A (zh) * | 2013-03-15 | 2016-01-06 | 加州生物医学研究所 | 用于诱导软骨形成的化合物和方法 |
CN106459076A (zh) * | 2014-05-13 | 2017-02-22 | 诺华股份有限公司 | 用于诱导软骨发生的化合物和组合物 |
-
2018
- 2018-04-23 WO PCT/US2018/028939 patent/WO2018200411A1/en unknown
- 2018-04-23 US US16/606,672 patent/US20210361600A1/en not_active Abandoned
- 2018-04-23 AU AU2018257769A patent/AU2018257769A1/en not_active Abandoned
- 2018-04-23 MA MA048479A patent/MA48479A/fr unknown
- 2018-04-23 EP EP18791842.0A patent/EP3615021A4/en not_active Withdrawn
- 2018-04-23 RU RU2019136884A patent/RU2019136884A/ru unknown
- 2018-04-23 JP JP2019555835A patent/JP2020517597A/ja active Pending
- 2018-04-23 KR KR1020197034179A patent/KR20190137904A/ko not_active Application Discontinuation
- 2018-04-23 CA CA3060518A patent/CA3060518A1/en active Pending
- 2018-04-23 CN CN201880042328.6A patent/CN110809468A/zh active Pending
-
2022
- 2022-12-07 JP JP2022195986A patent/JP2023071181A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012129562A2 (en) * | 2011-03-24 | 2012-09-27 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
CN105228626A (zh) * | 2013-03-15 | 2016-01-06 | 加州生物医学研究所 | 用于诱导软骨形成的化合物和方法 |
CN106459076A (zh) * | 2014-05-13 | 2017-02-22 | 诺华股份有限公司 | 用于诱导软骨发生的化合物和组合物 |
Non-Patent Citations (1)
Title |
---|
KRISTEN JOHNSON等: "A stem cell-based approach to cartilage repair", 《SCIENCE》 * |
Also Published As
Publication number | Publication date |
---|---|
EP3615021A1 (en) | 2020-03-04 |
WO2018200411A1 (en) | 2018-11-01 |
KR20190137904A (ko) | 2019-12-11 |
US20210361600A1 (en) | 2021-11-25 |
JP2023071181A (ja) | 2023-05-22 |
RU2019136884A (ru) | 2021-05-25 |
CA3060518A1 (en) | 2018-11-01 |
RU2019136884A3 (ru) | 2021-08-03 |
JP2020517597A (ja) | 2020-06-18 |
MA48479A (fr) | 2020-03-04 |
EP3615021A4 (en) | 2020-12-30 |
AU2018257769A1 (en) | 2019-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10882860B2 (en) | Treatment of osteoarthritis | |
US11980616B2 (en) | Treating liver disease by selectively eliminating senescent cells | |
US11517572B2 (en) | Killing senescent cells and treating senescence-associated conditions using a SRC inhibitor and a flavonoid | |
JP2023071181A (ja) | 軟骨形成を誘導するための方法 | |
Qian et al. | Downregulating PI3K/Akt/NF-κB signaling with allicin for ameliorating the progression of osteoarthritis: in vitro and vivo studies | |
BRPI0616324A2 (pt) | formulaÇço de cÁpsula de pirfenidona e excipientes farmaceuticamente aceitÁveis | |
KR20210151816A (ko) | 칸나비노이드 산 에스테르 조성물 및 이의 용도 | |
JPH11349480A (ja) | カルプロフェンおよび誘導体を用いた哺乳類における関節軟骨または軟骨下骨変性の初期段階の処置および予防 | |
KR20140069133A (ko) | 골다공증의 치료방법 | |
Staller | The effect of long-term antipsychotic treatment on prolactin | |
Kasatkin et al. | Nonsteroidal anti-inflammatory drugs causing local inflammation of tissue at the site of injection | |
WO2018229133A1 (en) | Tinostamustine for use in treating sarcoma | |
KR20190077131A (ko) | 선택적 s1p1 수용체 아고니스트를 포함하는 약학 조합물 | |
Zhang et al. | 11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis | |
Martini et al. | Combining a joint health supplement with tibial plateau leveling osteotomy in dogs with cranial cruciate ligament rupture. An exploratory controlled trial | |
JP6752001B2 (ja) | 上皮機能障害の処置におけるアデルミドロールの使用 | |
US20070248702A1 (en) | Use of CB2 receptors agonists for the treatment of Huntington's disease | |
WO2015120151A1 (en) | Topical formulation of a spiro-oxindole compound for treating pain associated with osteoarthritis of a joint | |
CN105491998B (zh) | 预防骨关节炎的方法和化合物 | |
WO2024088712A1 (en) | Mglur5 receptor antagonists for use in prevention and/or treatment of bone marrow lesions (bml) and/or osteoporosis, cartilage loss, osteosclerosis, osteitis in a mammal | |
Martini et al. | International Journal of Veterinary Science and Medicine | |
JP2020510001A (ja) | 非アルコール性脂肪性肝疾患と非アルコール性脂肪性肝炎の予防および/または処置に使用するための化合物 | |
Zhang et al. | Effects of pregnancy on progression of osteoarthritis induced by monosodium Iodoacetate in rats | |
Dassler et al. | Histological features of osteoarthritic canine cartilage after prolonged administration of carprofen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200218 |